These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8966311)

  • 21. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.
    Stelma FF; Sall S; Daff B; Sow S; Niang M; Gryseels B
    J Infect Dis; 1997 Jul; 176(1):304-7. PubMed ID: 9207389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of worm burdens in experimental schistosomiasis.
    Fulford AJ; Yeang F
    Parasitology; 1988 Oct; 97 ( Pt 2)():303-15. PubMed ID: 3143991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schistosoma mansoni: acquired immunity in mice after the use of oxamniquine at the evolutive skin and pulmonary phases.
    Coelho PM; Mello RT; Gerken SE
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):28-31. PubMed ID: 1843393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scanning electron microscopy of the tegumental surface of in vivo treated Schistosoma mansoni (Saudi Arabian geographical strain) with oxamniquine and praziquantel.
    Shalaby IM; Banaja AA; Ghandour AM
    J Egypt Soc Parasitol; 1991 Dec; 21(3):797-810. PubMed ID: 1765693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
    Thiong'o FW; Mbugua GG; Ouma JH; Sturrock RK
    East Afr Med J; 2002 Jan; 79(1):29-33. PubMed ID: 12380867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Praziquantel--its use, cost and possible development of resistance.
    Kusel J; Hagan P
    Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
    [No Abstract]   [Full Text] [Related]  

  • 27. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
    Lamberton PHL; Faust CL; Webster JP
    Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 33. Interventions for treating schistosomiasis mansoni.
    Saconato H; Atallah A
    Cochrane Database Syst Rev; 2000; (2):CD000528. PubMed ID: 10796552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined treatment of Biomphalaria glabrata infected by Schistosoma mansoni with oxamniquine and praziquantel: Reproductive histological and metabolic aspects.
    Lima RN; Coelho PMZ; Mattos ACA; Mello Silva CC; Augusto RC; Mota EM; de Souza S; Atella GC; Cabral SS; Gabriel Kluck GE; Faro MJ
    Exp Parasitol; 2017 Dec; 183():6-12. PubMed ID: 29017937
    [No Abstract]   [Full Text] [Related]  

  • 36. Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
    Beck L; Favre TC; Pieri OS; Zani LC; Domas GG; Barbosa CS
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():165-7. PubMed ID: 11586444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
    Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
    Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    Ann Trop Med Parasitol; 2001 Oct; 95(7):715-23. PubMed ID: 11784425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.
    Utzinger J; N'Goran EK; N'Dri A; Lengeler C; Tanner M
    Trop Med Int Health; 2000 Nov; 5(11):771-8. PubMed ID: 11123824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
    Lambertucci JR; Modha J; Curtis R; Doenhoff M
    Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.